Diatrizoate Meglumine vs Osimertinib
## Diatrizoate Meglumine vs Osimertinib: Overview
This comparison examines the pharmacological differences between **Diatrizoate Meglumine** and **Osimertinib**.
## Mechanism of Action
**Osimertinib**: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
## Pharmacokinetics
**Half-life**: Diatrizoate Meglumine — N/A; Osimertinib — 48 hours.
## Chemical Properties
**Molecular Formula**: Diatrizoate Meglumine — N/A; Osimertinib — C28H33N7O2.
**Molecular Weight**: Diatrizoate Meglumine — N/A; Osimertinib — 499.6050 g/mol.
**Type**: Diatrizoate Meglumine — Small molecule; Osimertinib — Small molecule.